Skip to main content
. Author manuscript; available in PMC: 2012 Oct 29.
Published in final edited form as: Urol Oncol. 2009 Dec 4;29(6):670–675. doi: 10.1016/j.urolonc.2009.10.003

Table 3.

Grade 3/4 hematological toxicity by cycle 1, use of G-CSF, and dose reductions

Cohort n Grade 3 neutropenia (%) Grade 4 neutropenia (%) Febrile neutropenia Use of G-CSF Dose reductions
1 3 3 (100) 1 (33) 0 No 0
2 3 3 (100) 2 (67) 0 No 2
3 4 3 (75) 2 (50) 0 No 0
4 3 3 (100) 3 (75) 0 No 2